Form D · Biotechnology
ADRX, Inc.
Thousand Oaks, CA · CIK 0001826290
Offering snapshot reported Dec 7, 2020 · SEC filing
- Reported sold
- $6M Offering amount: $6M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $60K Reported outside-investor minimum
- First sale
- Dec 1, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2020 | Initial | $6,000,000 | No comparison | 8 | SEC filing |
| Oct 13, 2020 | Amendment | $2,575,000 | $0vs Oct 2, 2020 | 19 | SEC filing |
| Oct 13, 2020 | Initial | $5,600,000 | No comparison | 22 | SEC filing |
| Oct 13, 2020 | Initial | $3,953,099 | No comparison | 12 | SEC filing |
| Oct 2, 2020 | Initial | $2,575,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-382470
Source: Form D, filed Dec 7, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marcin Apostol | Executive |
| Madhavan Balachandran | Director |
| John Frank | Director |
| Reza Halse | Director |
| Doug Lane | Executive |
| James Treanor | Director |
| David Wilcox | Executive |
| Gary Wilcox | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
515 Marin Street Suite 314
Thousand Oaks, CA, 91360
Thousand Oaks, CA, 91360